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Abstract
Dendritic cells (DCs) are professional antigen-presenting cells that
sample and present antigens to naïve T lymphocytes, which is necessary for 
the subsequent antigen-specific T-cell immune responses. DCs exist in a range 
of distinct subpopulations including plasmacytoid DCs (pDCs) and classical 
DCs (cDCs), with the latter consisting of the cDC1 and cDC2 lineages. 
Although the roles of DC-specific transcription factors across the DC subsets 
have become understood, the posttranscriptional mechanisms that regulate DC 
development are yet to be elucidated. MicroRNAs (miRNAs) are pivotal 
posttranscriptional regulators of gene expression in a myriad of biological 
processes, but their contribution to the immune system is just beginning to 
surface. To identify miRNAs possibly involved in DC development and 
function, we screened for the expression of candidate miRNAs that target the 
3’UTR of relevant transcriptional factors from our in-house probe collection.
We identified miR-124 which was able to target and directly regulate the 
expression of transcription factor Tcf4, a gene known to be critical for the 
development and homeostasis of pDCs. We then utilized an in vitro model for 
DC development using bone marrow (BM) culture with Flt3L, where miR-124
2was exceedingly expressed in pre-cDCs relative to the mature DC subsets
(pDC, cDC1, and cDC2). Meanwhile, the in vivo expression profiling of the 
subsets isolated from BM showed that miR-124 was outstandingly expressed 
in CD24+ cDC1s compared to DC precursors, pDCs, and CD172α+ cDC2s. We 
also investigated the effects of miR-124 mimic or inhibitor exaggeration on 
DC development to examine the phenotypic changes influenced by miR-124. 
Transfection of miR-124 mimic into BM common DC progenitors (CDP) 
followed by culture with Flt3L caused significant changes in resulting mature 
DC populations, where large decrease of a previously unrecognized DC subset 
was observed. These results imply mechanistic involvement of miR-124 in DC 
subset differentiation. These insights will provide further evidence into 
understanding a sophisticated process to regulate DC ontogeny where miR-124
plays a crucial role in DC development and function.
Key words: Dendritic cells, lineage development, microRNA, 
posttranscriptional regulation
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I. Introduction
Dendritic cells (DCs) are antigen-presenting cells (APCs) found in 
lymphoid organs as well as in tissue, especially those with interfaces exposed 
to the external environment. They essentially act as specialized sentinel cells 
that sample their local environment for antigens to present to naïve T 
lymphocytes, which is solely necessary for the subsequent antigen-specific T-
cell activation and induction of immune responses.11 When they were first 
described by Ralph Steinman in 1973, immunologists widely believed 
macrophages to be the main antigen-presenting cells in the immune system. 
While first deemed superfluous and their antigen-presenting capacity 
overshadowed by the physiological predominance of macrophages, dendritic 
cells have since been established to be the main APCs in our body and to play 
a crucial role in the innate and adaptive response to infection as well as in 
maintaining self-tolerance.1 Accordingly, DCs have garnered increasing 
scrutiny and their pivotal role in the orchestration of the innate and adaptive 
immune responses have made it an unavoidable target in studying disease and 
in understanding the human immune system.
4Many varieties of DC subpopulations have been described in both 
humans and mouse with each characterized by particular locations, phenotypic 
morphologies, and functions. In essence, DCs consist of a range of 
functionally distinct subsets that can be identified by their differential 
expression of particular surface markers.16 The DC subsets prevalent in the 
steady state include migratory DCs such as Langerhans cells (LCs), 
plasmacytoid DCs (pDCs), and lymphoid tissue-resident classical DCs 
(cDCs).16 LCs are generally present in the skin and mucosa, while lymphoid 
tissue-resident pDCs and cDCs can be found in the spleen and lymph nodes.  
pDCs are PDCA-1+, B220+ and mainly function in producing type I interferons. 
The lymphoid tissue-resident cDCs further segregate into different subtypes 
including CD8α+, CD24+, CD11b- cDC1, which efficiently cross-present 
antigens to CD8+ T cells and principally produce interleukin-12 p70 (IL-
12p70), and CD8 α-, CD11b+, CD172α+ cDC2, which present Class II 
restricted antigens to CD4+ T cells.4, 12, 14, 21 Also, more DC subtypes develop 
upon infection or inflammation such as the monocyte-derived inflammatory 
DCs (MoDCs).14 The common mouse and human matureDC subsets and the 
markers they carry along with their major functions are described in the chart 
in Figure 1. Immunologists have thus far used these phenotypic distinctions to 
characterize and attribute varying functions and physiological involvements to 
particular populations.
The development of DCs to their respective subset counterparts arise 
through a multistage process. Like all other immune cells, DCs develop from 
hematopoietic stem cells (HSCs) in the bone marrow (BM). HSCs differentiate 
into the myeloid progenitor (MP), which subsequently differentiates into the 
monocyte and DC progenitor (MDP) and then into the common DC progenitor
5(CDP).16, 20 CDPs develop into pre-DCs and pDCs and then egress from the 
bone marrow to the periphery. These cells seed peripheral secondary lymphoid 
tissues and non-hematopoietic tissues and ultimately mature into either cDCs 
or pDCs.12, 14 A comprehensive portrayal is shown in Figure 2. 
6Figure 1. Characteristics of matureDC subsets. Representative cDC1, 
cDC2, pDC, and monocyte-derived DC markers and function.
7Figure 2. Schematic view of DC ontogeny and development of distinct 
subsets. DC subsets with distinct functions and markers are generated from 
BM progenitor cells and the development of DCs to their respective subset 
counterparts arise through a multistage process.
8Development of DCs from their progenitor cells can be replicated in 
vitro with various culture conditions. Culture of DC progenitors with the 
growth factor fms-like tyrosine kinase-3 ligand (Flt3L) produces a 
heterogeneous population containing both cDCs and pDCs, which are 
equivalent to their in vivo counterparts with respect to cell surface marker 
expression, transcription factor reliance, cytokine production, receptor 
molecule expression, and antigen-presenting ability to T lymphocytes.11, 
17 Principally, the Flt3L-culture borne cells correspond to steady state 
populations.8, 11 DC development can also be modeled by culturing DC 
progenitors with granulocyte macrophage colony-stimulating factor (GM-
CSF). GM-CSF induces DCs that are more granular and produce more 
inflammatory mediators, such as tumor necrosis factor-α and interleukin-10.23
In essence, they are the in vitro equivalents of inflammatory MoDCs, and the 
generation of MoDCs from the in vitro culture of murine BM cells with GM-
CSF and IL-4 has been extensively described.11 The presence of Flt3L or GM-
CSF incites the progenitor cells to differentiate into their mature counterparts. 
The general ontogeny of the DC subpopulations is portrayed in Figure 3. 
Myeloid progenitor (MP) cells differentiate into macrophage-DC progenitors 
(MDP) in the BM. In the presence of GM-CSF, MDPs differentiate into 
monocytes and then into inflammatory DCs. In the presence of Flt3L, MDPs 
have the capacity to differentiate into common-DC progenitor (CDP). CDPs
further differentiate into pDCs or into pre-DCs that ultimately generate the 
cDC lineages. In essence, these in vitro culture systems that effectively 
simulate in vivo developments have allowed a grander accessibility to study 
the distinct functions of the varying subtypes. 
9Figure 3. DC fate is dependent on Flt3L and GM-CSF. Schematic showing 
the multistage process of DC development from BM progenitors to matureDC 
subsets depending on the inducing factor. 
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In light of these investigatory advances, the roles of transcription 
factors in DC development and their dynamic profiles across the subsets have 
become well understood. As for one, the transcription factor PU.1 has been 
described to play a role in the development of all DCs.15 Meanwhile, signal 
transducer and activator of transcription 5 (STAT5) is known to drive the 
development of cDCs in favor of pDCs through the inhibition of transcription 
factor interferon regulatory factor 8 (IRF8), whereas immunoglobin 
transcription factor 2 (TCF4) is known to drive pDC development over cDC 
by directly activating Irf8 and other pro-pDC transcription factors such as 
SpiB.3, 6, 15 As such, a comprehensive group of transcription factors and their 
involvement in the particular stages of DC development have been mapped. In 
contrast to these transcriptional mechanisms though, posttranscriptional 
mechanisms that regulate DC development are less well understood. With the 
heterogeneity of subsets and wide-ranging function of DCs, the natural 
question arises on how DC differentiation and development is regulated 
besides the orchestration of growth factors and transcription factors. Recently, 
increasing evidence has shown that microRNAs (miRNAs) play an important 
role in fine-tuning DC development and function.
miRNAs are an evolutionarily conserved class of short, endogenous, 
non-coding RNAs about 19~23 nucleotides long that regulate protein synthesis 
by targeting the complementary 3’ untranslated region (UTR) of messenger 
RNAs (mRNAs) for translational repression and degradation.8, 10 miRNA 
biogenesis begins with the transcription of a miRNA gene, which generates a 
primary miRNA transcript (pri-miRNA) through RNA polymerase II. The pri-
miRNA then bind DiGeorge syndrome critical region gene 8 (DGCR8) and the 
stem-loop structure is subsequently recognized and cleaved by the RNase III 
enzyme of endonuclease Drosha to release the hairpin pre-miRNA transcripts.6
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These transcripts are exported from the nucleus via Exportin-5, and the 
structures are further processed by Dicer to remove the loop and generate a 
miRNA duplex. A strand of the duplex is then segregated to give a mature 19-
to 23bp miRNA species which is incorporated into the RNA-induced silencing 
complex (RISC) assembly containing the Argonaute (Ago) protein. The 
assembly ultimately targets mRNAs for translational repression or degradation. 
A key characteristic of miRNAs is that each has the ability to inhibit a myriad 
of mRNAs, and each mRNA can be targeted by many miRNAs.8, 10, 23 This 
sketches a complex network of miRNAs surrounding DC development. 
miRNAs have been shown to be vital in controlling many processes 
within the immune system.1, 10 Their involvement in regulating T- and B-
lymphocyte development has been established of late and their wide-ranging 
roles in cell differentiation, homeostasis, cytokine responses, and interactions 
with pathogens and tolerance induction among others have been described.8, 9, 
23, 24 More recent progressions have attempted to describe the role of miRNAs 
in DC development. Several miRNAs have been specifically attributed to the 
direct regulation of certain DC functions and more have been identified by the 
mapping of dynamic profiles across the subsets.10, 23 More specifically, recent 
research has emphasized the requirement of miRNAs in DC lineage 
commitment from BM progenitors and for the development of certain subsets.8
Cluster analyses across isolated subsets have shown a differential expression 
of miRNA throughout the developmental process of murine DC.13, 23 In a 
particular study, Su et al., used next-generation deep sequencing to 
demonstrate that 391 miRNA were differentially expressed during DC 
differentiation.24 For example, mir-123 and miR-147 were highly expressed in 
both immature and mature subsets but not in HSCs.10 These distinct miRNA 
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profiles and indications of miRNA involvement can also be observed among 
DC subsets and linked to particular transcription factors and functional 
properties.10, 13 Immunologists have subsequently used knockout and 
overexpression studies to identify miRNAs along with corresponding 
transcription factors and their involvement in the development of particular 
subset populations as well as their affect on regulating DC homeostasis, 
cytokine profiles, and immune response induction capabilities among others.8-
10, 13 Mildner et al. observed that miR-125, let-7 and miR-21 were 
differentially expressed throughout pDCs, CD8α+ cDCs, and CD4+ cDCs.13 In 
a more particular example, Zhou et al. recently described that miRNA-146a 
and -146b regulate the apoptosis and cytokine production of moDCs by 
targeting TRAF6 and IRAK1 proteins.18
This increasing body of literature highlights the importance of specific 
miRNAs in DC development and regulation of their functional capacities. Like 
such, recent efforts have started to uncover the vast network of miRNAs that 
manipulate the biogenesis and mechanics of DCs; however, current knowledge 
is merely at the tip of the iceberg and though these studies have given such 
insight and building curiosity on the topic, the role of miRNAs in DC 
development and function remain largely elusive. Given the unique role of 
DCs in linking the innate and adaptive immune system, understanding how 
miRNAs affect DC function and development may be critical for 
understanding diseases and the immune system as a whole as well as providing 
insights into a novel target for therapeutic use and clinical application.
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II. Materials and Methods
2.1 Mice
All experimental procedures for animal studies were approved by the 
Institutional Animal Care and Use Committee (IACUC) of Yonsei University 
College of Medicine. C57BL/6 mice were purchased from Orient Laboratories 
(Seongnaml, Korea) and sacrificed at 6 to 8 weeks of age. CD45.1 and CD45.2 
mice (all congenic on the C57BL/6 background) for transfection experiments 
were purchased from The Jackson Laboratory (Bar Harbor, ME) and bred for 
use at 6 to 10 weeks of age. Only healthy male mice were used in this study. 
Mice were bred at the Department of Laboratory Animal Resources at the 
Avison Biomedical Research Center of Yonsei University in specific pathogen-
free conditions.
2.2 Bone marrow extraction
Mice were sacrificed by asphyxiation in a CO2 chamber. The hindlegs 
of the mice were excised and BM was flushed from the femur and tibia with 
Dulbecco’s modified Eagle’s medium (DMEM; HyClone Laboratories, Logan, 
UT) in sterile conditions. The extraction was then passed through a 100μm 
Nylon cell strainer to make single-cell suspensions. The cells were then 
washed multiple times with DMEM.
2.3 Splenocyte preparation
Mice were sacrificed and spleens of the mice were extracted. Whole 
splenocyte suspensions were prepared by cutting and mincing the extracted 
whole spleens, grinding up the spleens with frosted glasses in DMEM, and 
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then passing the cells through a strainer. Cells were washed multiple times 
with DMEM.
2.4 Cells, antibodies, and reagents
Chinese hamster ovary (CHO) cells (CHO-S cells; Gibco, Life 
Technologies, Carlsbad, CA) were cultured in DMC7 medium composed of 
DMEM containing L-glutamine, high glucose, and pyruvate (HyClone) and 7% 
fetal bovine serum (FBS; HyClone) supplemented with 1x solutions of non-
essential amino acids and antibiotic-antimycotic (HyClone). The 
aforementioned mouse primary cells were used directly for steady-state
experiments or were cultured in various dilutions of Flt3L-conditioned 
medium produced in our lab as described in below for in vitro experiments. 
The following conjugated antibodies were purchased from BioLegend (San 
Diego, CA): APC-Cy™7-conjugated anti-I-A/I-E, anti-CD11c, anti-
B220/CD45R, anti-CD45, anti-Rat IgG2b κ Isotype Control; Alexa Fluor® 
647-conjugated anti-CD117; APC-conjugated anti-B220/CD45R, anti-PDCA-
1 (BST2, CD317), anti-CD135; PE-Cy™7-conjugated anti-Ly6G, anti-CD3, 
anti-CD11c, anti-CD19, anti-Ter119, anti-DX5, anti-I-A/I-E, anti-NK1.1, anti-
Gr-1, anti-Sca-1; PerCP-Cy™5.5-conjugated anti-Ly6C, anti-CD11c, anti-
CD24, anti-CD117, anti-CD172α (Sirpα); PE-conjugated anti-SiglecH, anti-
CD11c, anti-CD115, anti-CD117, anti-CD135, anti-Armenian Hamster (AH) 
IgG Isotype Control; FITC-conjugated anti-CD172α; Alexa Fluor® 488-
conjugated anti-Ly6C, anti-CD172α, anti-PDCA-1, anti-CD24, anti-CD45.2; 
Brilliant Violet™ 421 (BV421)-conjugated anti-CD11c, anti-CD45.1, anti-
CD45.2, anti-CD115, anti-AH IgG Isotype Control; biotin-conjugated anti-
NK1.1, anti-DX5, anti Ter119, anti-Ly6G, anti-CD3, anti-CD19, anti-CD135. 
LIVE/DEAD® fixable dead cell stain kit (Life Technologies) and propidium 
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iodide (Roche, Indianapolis, IN) were purchased and used according to the 
manufacturer’s instructions.
2.5 Production of Flt3L from Chinese hamster ovary (CHO) cells
The cDNA of mouse Flt3L was cloned by RT-PCR of total splenic 
RNA from C57BL/6 mice, and was used to generate a construct encoding 
soluble FLAG and OLLAS tagged Flt3L, internal ribosomal entry site (IRES), 
and enhanced green fluorescence protein (EGFP), i.e., SFO.Flt3L-IRES-
EGFP.19 The GenBank accession number for the sequence for the extracellular 
domain of Flt3L is GU168042, and the IRES-EGFP sequence is from pIRES-
EGFP plasmid (Clontech, Mountain View, CA). CHO cells were then 
transfected using Lipofectamine 2000 (Life Technologies), with a mammalian 
expression vector plasmid encoding SFO.Flt3L-IRES-EGFP under CMV 
promoter and a neomycin resistance gene, generated with the backbone of 
pEGFP-N1 (Clontech). CHO/Flt3L cell-lines stably expressing the SFO.Flt3L-
IRES-EGFP were generated by the following steps: (i) treatment of 
transfectant CHO cells with G418 (1.5mg/ml) for 1 week; (ii) enrichment of 
EGFP-positive CHO cells with FACSAria II cell sorter (BD Biosciences); (iii) 
generation of clonal cells by limiting dilutions of FACS-sorted EGFP-high 
CHO/Flt3L cells; and (iv) selection of CHO/Flt3L clones after testing both 
levels of EGFP expression by FACS and Flt3L secretion by anti-OLLAS 
Western blot.19 Selected CHO/Flt3L cells were cultured in cell culture bags 
(LAMPIRE, Pipersville, PA) with DMC7 to produce CHO/Flt3L-conditioned 
medium.
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2.6 Flow cytometry
Single cell suspensions were prepared from the harvest of mouse 
organ tissues or cultures thereof, incubated with 2.4G2 (Fc blocker) hybridoma 
supernatant, and washed with FACS buffer. Then, each sample was incubated 
with the appropriate mixture of fluorochrome-conjugated monoclonal 
antibodies and live/dead staining dyes described above. Cells were incubated 
for 30 min at 4°C and then washed with FACS buffer (2% FCS, 2 mM EDTA, 
0.001-0.1% sodium azide) twice prior to analysis with FACSVerse flow 
cytometer (BD Biosciences, San Diego, CA) or sorting with FACSAria II cell 
sorter (BD Biosciences). Flow cytometric data were analyzed using FlowJo 
software (FlowJo, Ashland, OR).
2.7 RNA isolation and real-time PCR
2.7.1 RNA isolation
Total RNA was isolated from sorted cells from cultured or uncultured 
mouse primary cells using TRIzol® Reagent (Life Technologies). The 
SYBR® Green and TaqMan™ systems were used to detect gene expression.
2.7.2 TaqMan™ real-time PCR
For miR-124 expression profiling, 100 ng of purified total RNA was 
used for reverse transcription (Taqman® MicroRNA Reverse Transcriptase 
Kit, Applied Biosystems, Foster City, CA). The resultant cDNA was used in 
combination with Taqman® MicroRNA Assays mmu-miR-124a and U6 
control transcripts and Taqman® Universal Master Mix II  for PCR 
according to the manufacturer’s instructions. The mature mmu-miR-124a 
(mmu-miR-124-3p, MIMAT0000134) sequence is 5’-
UAAGGCACGCGGUGAAUGCC - 3’. The amplification and detection of 
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products were performed in a Light Cycler 480 II (Roche) with an initial 
denaturation at 95°C for 10 min, followed by 40-60 cycles of amplification at 
95°C for 15 s and 60°C for 60 s before cooling. The threshold cycle (Ct) of 
miR-124 expression was automatically defined, located in the linear 
amplification phase of the PCR, and normalized to the control U6 (ΔCt value). 
The relative difference in expression levels of miR-124 in the sorted cells 
(ΔΔCt) was calculated and presented as the fold induction (2-ΔΔCt). 
2.7.3 SYBR® Green real-time PCR
For pri-miR-124 and relevant transcription factor profiling, 100 ng of 
purified total RNA was used for reverse transcription (PrimeScript™ RT 
Reagent Kit, TaKaRa Bio Inc., Ohtsu, Japan). The resultant cDNA was used in 
combination with designed short oligonucleotides (Cosmo Genetech, Seoul, 
Korea) and SYBR® Premix Ex Taq II (TaKaRa) for PCR according to the 
manufacturer’s instructions. The primers sequences for the transcription 
factors were designed and produced by Cosmo Genetech. The primer 
sequences for the precursor transcripts of mmu-miR-124 are as follows: pri-
miR-124-1, 5’-GCCTCTCTCTCCGTGT-3’ forward, 5’-
CCATTCTTGGCATTCA-3’ reverse; pri-miR-124-2, 5’-
AGAGACTCTGCTCTCCGTGT-3’ forward, 5’-CTCCGCTCTTGGCATTC-
3’ reverse; pri-miR-124-3, 5’-GGCTGCGTGTTCACAG-3’ forward, 5’-
ATCCCGCGTGCCTTA-3’ reverse; GAPDH, 5’-
ACAGTCCATGCCATCACTGCC-3’ forward, 5’-
GCCTGCTTCACCACCTTCTTG-3’ reverse. The amplification and detection 
of products were performed in a Light Cycler 480 II (Roche) with an initial 
denaturation at 95°C for 5 min, followed by 40-60 cycles of PCR at 95°C for 5 
sec and 50°C for 30 sec, before melting at 95°C for 5 sec and 60°C for 1 min. 
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The relative difference in expression levels for pri-miR-124-1/-2/-3 in the 
sorted cells was calculated and presented as described above but with 
normalization to the control GAPDH. 
2.8 Luciferase activity assay
The predicted target genes of miR-124 were identified using a public 
database (miRWalk2.0, http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk). 
Sections containing the miR-124 binding site of the 3’UTR of Tcf4(v2) and 
Zbtb46 were cloned into pmirGLO vectors, independently. 2.5x104 HeLa cells 
were seeded in a 24-well plate. After 48 hrs, the pmirGLO vector containing 
the target mRNA binding site for the miR was co-transfected with mmu-miR-
124 mimic (TaqMan®) or the negative control using Lipofectamine 2000 
(Invitrogen Co, Carlsbad, CA). Luciferase activity was measured after 48 hrs 
using Dual Luciferase Assay (Promega Corporation, Fitchburg, WI) according 
to the manufacturer’s instructions on a luminometer (Promega). Renilla
luciferase was used to normalize the transfection efficiency. Each assay was 
repeated at least 3 times. 
2.9 miR-124 mimic/inhibitor transfection
miRCURY Locked Nucleic Acid (LNA) microRNA Mimic (hsa-miR-
124-3p), miRCURY LNA Mimic Control (cel-miR-39-3p), miRCURY LNA 
Power Inhibitor (mmu-miR-124-3p), and miRCURY LNA Power Inhibitor 
Control from Exiqon (Cambridge, MA) were used at 100 uM. CDPs were 
transfected with oligonucleotides by nucleofection using Amaxa® P4 Primary 
Cell 4D-Nucleofector® X Kit (Lonza, Cologne, Germany) reagents and the 
4D-Nucleofector® X Unit (Lonza) according to the manufacturer’s 
instructions.
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2.10 Culture of CDPs and miR-124 transfection
CDPs were sorted from fresh BM of CD45.2 mice. After nucleofection 
with the appropriate miR-124 mimic, inhibitor, or control oligonucleotides 5 x 
103 to 1.5 x 104 sorted CDPs were co-cultured with 5x106 BM cells from 
CD45.1 mice in 6-well plates using 25% Flt3L-conditioned media. Flow 
cytometry was used to assess the growth pattern of the CDP populations on 
day 2 and 4 post-seeding. 
2.11 Statistical analysis
The results are expressed as the mean ± SD from at least three independent 
experiments. Statistical analyses were performed using Student’s t-test. 
Comparisons between more than two groups were performed by one-way 
ANOVA using Bonferroni’s correction. Relations were considered statistically 
significant when the p < 0.01
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III. Results
3.1 Candidate miRNAs related to DC development
To identify miRNAs possibly involved in DC development, an online 
miRNA prediction software (miRWalk2.0) which amalgamates data from a 
collection of miRNA-target prediction programs was used. Ten gene targets 
that are prominently known to have a pivotal role in DC development – Tcf4, 
Bcl6, Irf2, Irf4, Irf8, Id2, SpiB, Batf3, Notch2, Zbtb46 – were picked for the 
prediction software to identify miRNAs that possibly regulate these genes by 
binding to their 3’UTR. From the provided candidate list of miRNAs that have 
a high potential to bind to these transcription factors, candidates with primers 
that were accessible in an in-house library probe collection, provided in 
courtesy of Professor Ki-Chul Hwang, were picked out. Figure 4 shows the 
3’UTR map diagram of the 10 transcription factors and the binding sites of the 
candidate miRNAs. Overall, 20 candidate miRNAs were specified. This 
allowed identification of miRNAs that potentially bind to the 3’UTR of these 
essential transcription factors, regulate their activity, and affect DC 
development.
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Figure 4. Identification of candidate miRNAs that potentially target the 
transcript of transcription factors in DC development. miRWalk2.0 was 
used to identify miRNAs with high probability to bind to the 3’UTR of the 
listed transcription factors. miRanda, miRWalk, miRDB, PITA, RNA22, and 
TargetScan prediction algorithms were used and miRNAs with significant 
scores from at least 3 of the algorithms were listed (SUM ≥ 3). (A) Candidate 
list of miRNAs that target Tcf4 and the map diagram of Tcf4 3’UTR with the 
predicted binding sites of the candidates. The same is shown for (B) Bcl6, (C) 
Irf2, (D) Irf4, (E) Irf8, (F) Id2, (G) SpiB, (H) Batf3, (I) Notch2, and (J) Zbtb46.
26
3.2 miR-124 is outstandingly expressed in DC subset
In preliminary efforts to identify unmentioned miRNA that may play a 
role in DC development, expression profiles were observed in both the GM-
CSF and Flt3L culture systems of murine BM cells. Initial screenings of 
miRNAs in the GM-CSF culture system saw a drastic increase in the 
expression of miR-155 in correlation with the differentiation into MoDCs. 
This was corroborated in a recent corresponding publication by Reith et al. 
which explained the importance of miR-155 in the silencing of c-Fos 
expression for the development and functional maturation of MoDCs.5
miRNA expression profiles were then observed in the Flt3L culture 
system. More specifically, for further evidence of miRNAs possibly involved 
in DC differentiation, the in-house probe collection was used to perform an 
initial expression screening of the candidate miRNAs in BM B220- cDCs and 
B220+ pDCs. The RNAs of these two general matureDC subsets generated by 
Flt3L-conditioned media were isolated and the expression profile of the 
candidate miRNAs were observed by real-time PCR. Normalization to the 
lowest expression showed an exceedingly high relative expression of miR-124 
in B220- cDCs compared to other candidate miRNAs (Figure 5A). 
Normalization to each individual candidate miRNA showed that most 
miRNAs are expressed more in B220- cDCs except for miR-17 (Figure 5B). 
The outstanding expression of miR-124 in B220- cDCs and its contrasting 
expression between the two DC groups hint that miR-124 may be expressed 
differentially within DC ontogeny and may play a role in their development.
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Figure 5. Initial expression screening of candidate miRNAs. (A) Real-time 
PCR screening showing relative expression levels of candidate miRNAs in 
BM B220- cDCs and B220+ pDCs. (B) Expression levels of candidate 
miRNAs normalized to individual candidate miRNA probes.
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3.3 miR-124 might directly regulate Tcf4 activity
In light of the previous data, focus was concentrated on miR-124 to 
uncover if it may have a role in DC development. The prediction algorithm 
programs were used to see the possible transcription factor targets of miR-124. 
miR-124 was shown to have a high probably of binding to the 3’UTR of Tcf4 
(Figure 4A). miR-124 was also predicted to bind to Zbtb46 (not shown in 
chart ∴ SUM < 3). To see whether miR-124 actually binds to these genes, a
dual luciferase reporter assay was performed. A section, 342bps, of the 3’UTR 
of Tcf4 containing the predicted binding site of miR-124 was inserted into the 
multiple cloning site (MCS) of a pmirGLO vector (Figure 6A). A 480bp 
section of the 3’UTR of Zbtb46 was done the same (Figure 6B). The cloned 
vectors were co-transfected with miR-124 mimic or the negative control into 
HeLa cells and the luciferase activity was measured. The assay showed that 
the overexpression of miR-124 caused a decrease in luciferase activity of the 
pGLO-Tcf4 vector (~30%) while not that of pGLO-Zbtb46 (Figure 6C). This 
indicates that miR-124 directly binds to the 3’UTR of Tcf4 and regulates its 
activity. Mentioned before, Tcf4 is a critical gene in the development and 
homeostasis of pDCs.3 Together these findings suggest that miR-124 may 
directly regulate Tcf4 activity and play a pivotal role in DC development.
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Figure 6. miR-124 directly regulates the 3’UTR of Tcf4. (A) pmirGLO 
vector map diagram. (B) Map diagram of pmirGLO vector with section of Tcf4 
3’UTR containing the predicted binding site for miR-124 inserted into the 
MCS. (C) Map diagram of pmirGLO-Zbtb46 vector. (D) Dual luciferase 
reporter assay of the clone vectors shows luciferase activity in pGLO-Tcf4 and 
pGLO-Zbtb46 after treatment with miR-124 mimic or control mimic.
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3.4 Bone marrow cells differentiate into distinct subsets upon culture with 
Flt3L
In order to verify the developmental pattern of DC subsets as 
described in previous publications, time-course analyses of DC development 
in Flt3L culture was performed.16 First, to optimize culture conditions, a time-
course analysis of DC subsets was performed with serial dilutions of Flt3L. A 
Flt3L titration culture of murine BM cells was performed and the development 
of subsets were analyzed by flow cytometry every 2 days for 10 days. The pre-
DC subset was broadly gated as CD11c+MHCII- (Figure 7A). pDC population 
was defined as CD11c+B220+ cells (Figure 8A), while cDC1 and cDC2 
lineages were defined as CD11c+B220-CD24hiCD172α- and CD11c+B220-
CD24loCD172α+ respectively (Figure 9A). The results indicated 25% Flt3L-
conditioned media sufficiently provided hospital environments for pre-DCs 
(Figure 7) or matureDCs to thrive (Figure 8, 9). Higher concentrations were 
able to induce DC differentiation and maturation more efficiently as 
previously described.22 The overall BM DC growth patterns in Flt3L-
conditioned media were similar to the observations made by Shortman et al.16
and Murphy et al.15 The pre-DC subset showed to initially decrease in number, 
increase up to 4 to 6 days post-culture, and then steady decline in further 
culture (Figure 7B,C). The pDC population showed to generate abundantly
starting from day 4 post-culture, peak at day 6 post-culture, and plateau in 
number until day 10 post-culture (Figure 8B). Meanwhile, both cDC1 and 
cDC2 lineages showed to steadily increase in number and peak at day 8 post-
culture before declining (Figure 9B). These data allowed formulation of a 
proficient system of BM DC subset culture with 25% Flt3L-conditioned media, 
and provided a guiding frame for further isolation studies.
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Figure 7. In vitro generation of pre-DCs by culture of BM cells with Flt3L. 
Mouse BM cells were cultured in various concentrations of Flt3L-conditioned 
media for 10 days. (A) Time-course FACS analysis of CD11c+MHCII- cells 
every 2 days for 10 days in culture with 25% Flt3L-conditioned media. BM 
cells were seeded in 24-well plates at 1x106 cells per well. (B) Graphical 
representation of CD11c+MHCII- cell number over 10 days of culture in 
various concentrations of Flt3L. (C) Graphical representation of 
CD11c+MHCII- cell number and CD135+ pre-DC cell number over 8 days in 
culture with 25% Flt3L-conditioned media.
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Figure 8. In vitro generation of pDCs by culture of BM cells with Flt3L. 
Mouse BM cells were cultured in Flt3L-conditioned media for 10 days. (A) 
Time-course FACS analysis of pDC population gated as CD11c+MHCII-B220+
cells every 2 days for 10 days in 25% Flt3L-conditioned media. BM cells were 
seeded in 24-well plates at 1x106 cells per well. (B) Graphical representation 
of pDC cell number over the 10 days in 25% Flt3L-conditioned media.
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Figure 9. In vitro generation of cDCs by culture of BM cells with Flt3L. (A) 
Time-course FACS analysis of cDC1 and cDC2 lineages gated as 
CD11c+MHCII+B220-CD24hiCD172α- and CD11c+MHCII+B220-
CD24intCD172α+, respectively, every 2 days for 10 days in 25% Flt3L-
conditioned media. BM cells were seeded in 24-well plates at 1x106 cells per 
well. (B) Graphical representation of cDC1 cell number and (C) cDC2 cell 
number over 10 days in 25% Flt3L-conditioned media.
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3.5 pre-DCs cultured in vitro with Flt3L show high expression of miR-124 
Before examining miRNA levels or any further relevant data, DC 
subtypes must be successfully isolated from the Flt3L culture system of 
murine BM cells. In a publication by Shortman et al., the authors demonstrate 
a high yield isolation of three DC populations through the culture of bone 
marrow cells with Flt3L for 8 to 10 days. These populations are segregated 
into CD11c+B220hi pDCs and CD11c+B220lo cDCs. The cDC population is 
shown to be further separated into cDC1 and cDC2 subpopulations using 
CD24 and CD172α markers. The authors also demonstrate the efficient 
isolation of pre-DCs with full capacity to form other hematopoietic lineages 
and DCs from BM cells after 3.5 days of Flt3L culture. The time frame was 
determined to offer a high yield of pre-DCs with most irrelevant cells dead and 
their proliferative potential least diminished.16 These findings are further 
corroborated in other publications which demonstrate the isolation of DC 
subsets by Flt3L culture of murine BM cells and subsequently performing 
FACS using selected surface markers.14 Together with the optimized Flt3L 
culture system delineated in Figure 7-9, these guidelines were followed to sort 
and isolate pre-DC, pDCs, and cDC subsets. After experimentation with a 
combination of surface markers and strategies, population sorting was 
optimized to a good yield (purity > 90%). Pre-DCs were isolated by sorting for 
CD11c+MHCII-CD135+ cells after 4 days of 25% Flt3L-conditioned media 
culture of murine BM cells (Figure 10A). MatureDC populations were 
isolated 10 days after culture of BM cells with 25% Flt3L-conditioned media
and sorted as follows: CD11c+B220+ for pDC (Figure 10B); CD11c+B220-
CD24hiCD172α- for cDC1; and CD11c+B220-CD24intCd172α+ for cDC2 
(Figure 10C). 
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After successful sorting of the in vitro-generated DC subsets, the RNA 
of the isolated cells were extracted. Real-time PCR of the RNAs with the 
mmu-miR-124 primer showed an exceedingly high relative expression of miR-
124 in pre-DCs compared to the matureDC subsets (Figure 10D). The 
expression of miR-124 in pre-DCs was compared to that of CD11c+MHCII-
CD135- negative control cells sorted from the same mice to confirm that the 
high expression was in fact restricted to the sorted pre-DC population (Figure 
10E). There was also a repeated pattern of high expression in cDC1 cells 
among the cultured matureDC subsets (Figure 10F). 
As mentioned before, the dynamic expression of pivotal transcription 
factors across DC subsets have been described.14 Real-time PCR with the 
probes of selected transcription factors were performed with the RNA of the 
sorted subsets. The genes observed were: TCF4, IRF8, SFPI1, SPIB, STAT3, 
GFI, BATF3, and ID2. The expression profile of TCF4, BATF3, and IRF8 are 
shown in Figure 10G. The overall patterns of transcription factor expression 
across the subsets isolated from in vitro Flt3L culture were parallel to 
previously reported patterns indicating genuity of the isolated subsets.14 TCF4 
showed to have high expression in pDCs, while BATF3 and IRF8 showed high 
expression in cDC1 cells. This correlates with conclusions made by Murphy et 
al.15
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Fig
ure 10. Isolation of BM DC subsets generated in vitro and miR-124 
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expression. BM cells were cultured with  25% Flt3L-conditioned media in 
12-well plates at 1x107 and 3x106 cells per well for preDC and matureDC 
analysis respectively. (A) pre-DCs were sorted as CD11c+MHCII-CD135+ cells 
on day 4. CD135- cells were sorted for negative control. (B) pDCs were sorted 
as CD11c+B220+ cells on day 10. (C) cDC1s were sorted as CD11c+B220-
CD24hiCD172α- cells and cDC2s were sorted as CD11c+B220-
CD24intCD172α+ on day 10. (D) miR-124 expression of the sorted subsets was
observed by real-time PCR. (E) Real-time PCR with the negative control 
shows that the relatively high expression of miR-124 was restricted to CD135+
pre-DCs. (F) miR-124 expression representation without pre-DC subset. (G) 
Real-time PCR showing the relative expression of TCF4, BATF3, and IRF8 
across the sorted DC subsets. Representative data from 3 independent 
experiments are shown.
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3.6 cDC1 cells in BM show high expression of miR-124
To observe miR-124 expression profiles in steady-state BM, cells 
were sorted from fresh BM extracted from C57BL/6 mice. Sorting strategies 
were formulated with similar parameters to those previously mentioned. Pre-
DCs were isolated by sorting for CD11c+MHCII-CD135+ from the fresh BM 
extraction as before. MDP and CDP progenitor cells from BM were also 
isolated as Lin-CD11c-CD115+CD135+CD117hi and Lin-CD11c-
CD115+CD135+CD117int following previously established parameters (Figure 
11A).16 Lineage markers used for the progenitor isolation were Ly6G, CD19, 
Ter119, MHCII, B220, CD3, and NK1.1. pDCs were isolated as Lin-
B220+PDCA-1+ cells (Figure 11B). cDC1 and cDC2 lineages were isolated as 
Lin-CD11c+B220-CD24hiCD172α- and Lin-CD11c+B220-CD24intCd172α+, 
respectively (Figure 11C). Lineage markers used for matureDC isolation were 
Ly6G, CD19, Ter119, CD3, NK1.1, and DX5. Real-time PCR of the extracted 
RNA showed a relatively high expression of miR-124 in the cDC1 lineage 
compared to other matureDC subsets and progenitor populations (Figure 11D). 
A difference in miR-124 profile was observed in that miR-124 was 
expressed highly in pre-DCs from cultured BM but not in pre-DCs from 
steady-state BM in situ (Figure 10D, Figure 12B). In a publication by 
Murphy et al., the authors demonstrate that the pre-DC subset can be further 
segregated into pre-pDC/cDC2, pre-cDC1, and pre-cDC2 (nomenclature 
coined here).6 The authors noted that CD115 and CD117 markers could be 
used to discriminate these pre-DC subpopulations. The cells isolated by these 
methods were observed to develop in a committed manner to particular 
matureDC subsets.6 To determine whether the high relative expression of miR-
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124 in cultured pre-DCs could be due to a particular pre-DC subpopulation 
committed to a particular matureDC subset, the three subpopulations were 
analyzed. The pre-DC subpopulations were all sorted for the previously 
described markers as CD11c+MHCIIlo-intCD135+ cells. From here, pre-
pDC/cDC2 was sorted as CD117-CD115-, pre-cDC1 was sorted as 
CD117+CD115+, and pre-cDC2 as CD117-CD115+ (Figure 12A). The RNA of 
the sorted pre-DC subpopulations and matureDC subsets were extracted and 
used for real-time PCR. The cDC1 lineage showed higher expression of miR-
124 than the overall pre-DC population as well as in other matureDC subsets 
(Figure 12A). All three pre-DC subpopulations showed low relative 
expression of miR-124 compared to cDC1 indicating that a particular 
subpopulation of pre-DC was not responsible for the high expression of miR-
124 in cultured pre-DCs (Figure 12C). 
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Figure 11. Isolation of steady-state BM DC subsets and miR-124 
expression. Cells were sorted from fresh mouse BM. (A) MDPs and CDPs
were sorted as Lin-CD11c-CD115+CD135+CD117hi and Lin-CD11c-
CD115+CD135+CD117int, respectively. (B) pDCs were sorted as Lin-
B220+PDCA-1+. (C) cDC1s were sorted as Lin-CD11c+MHCII+B220-
CD24hiCD172α- and cDC2s as Lin-CD11c+MHCII+B220-CD24intCD172α+. (E) 
miR-124 expression in steady-state BM DC subsets.
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Figure 12. Isolation of pre-DC subpopulations in steady-state BM and 
miR-124 expression. Cells were sorted from fresh BM. (A) pre-DC 
subpopulation sorting strategy. pre-pDC/cDC2: Lin-CD11c+MHCIIlo-intCD117-
CD115-. pre-cDC1: Lin-CD11c+MHCIIlo-intCD117-+CD115+. pre-cDC2: Lin-
CD11c+MHCIIlo-intCD117-CD115+. (B) miR-124 expression in pre-DC and 
matureDCs by real-time PCR. (C) miR-124 expression in pre-DC 
subpopulations and matureDCs by real-time PCR. 
3.7 cDC1 cells in spleen show high expression of miR-124 
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To observe the patterns of miR-124 expression profiles in steady-state 
spleen, cells were sorted from fresh spleen extracted from C57BL/6 mice. 
Sorting strategies were formulated with similar parameters to those previously 
mentioned. Pre-DCs were isolated by sorting for CD11c+MHCII-CD135+ from 
the freshly extracted splenocytes (Figure 13A). pDCs were isolated as Lin-
SiglecH+B220+ cells (Figure 13B). cDC1 and cDC2 lineages were isolated as 
Lin-CD11c+MHCII+B220-CD24hiCD172α- and Lin-CD11c+MHCII+B220-
CD24intCd172α+, respectively (Figure 13C). Lineage markers used were: CD3, 
CD19, DX5, and B220. Real-time PCR of the extracted RNA from the sorted 
cells showed a relatively high expression of miR-124 in the cDC1 lineage 
compared to other subsets (Figure 13D).
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Figure 13. Isolation of steady-state spleen DC subsets and miR-124 
expression. Cells were sorted from fresh mouse splenocytes. (A) pre-DCs 
were sorted as Lin-CD11c+MHCII-CD135+. (B) pDCs were sorted as Lin-
SiglecH+B220+. (C) cDC1s were sorted as CD11c+B220-CD24hiCD172α- and 
cDC2s were sorted as CD11c+B220-CD24intCD172α+. (D) miR-124 expression 
of the sorted subsets was observed by real-time PCR.
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3.8 All three miR-124 precursor transcripts contribute to miR-124 
expression in cDC1cells
As mentioned before, miR-124 has three primary miRNA genes: pri-miR-
124-1, pri-miR-124-2, and pri-miR-124-3. Three transcripts originate from 
these three different genes on separate chromosomes but all translate into the 
same mature miR-124 sequence. The map diagram detailing the origins of the 
precursor transcripts are shown in Figure 14A. Oligonucleotide probes were 
appropriately designed and real-time PCR was performed to determine which 
of the possible three precursor transcripts were expressed in DC subsets. 
Expression profiling in the cDC1 lineage from steady-state BM (Figure 14B) 
and steady-state spleen (Figure 14C) showed similar patterns of miR-124 
precursor expression. Both studies showed that pri-miR-124-1 was expressed 
the least and pri-miR-124-3 was expressed the most but all precursors were 
expressed significantly within 2~3 fold of each other. The precursor miR-124 
gene expressions were also measured in other DC subsets, which showed that 
all three genes contribute variably in different DC subsets (not shown). In 
other words, the definitive expression of all three miR-124 precursors indicates 
that they all contribute significantly to mature miR-124 expression.
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Figure 14. Contribution of the three miR-124 precursors to miR-124 
expression in DC subset. (A) Map diagram showing the origins of the three 
miR-124 precursor transcripts. (B) Real-time PCR analysis showing relative 
miR-124 precursor expression in cDC1 cells from steady-state BM. (C) 
Relative miR-124 precursor expression in cDC1 cells from steady-state spleen. 
Representative data from 3 independent experiments are shown.
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3.9 Overexpression of miR-124 causes significant changes to in vitro-
cultured DC populations
Ginhoux et al. described an experimental apparatus where isolated BM 
CDPs can be re-cultured with BM filler cells and observed for developmental 
patterns.21 BM from CD45.2 mice were extracted and sorted for CDPs. CDPs 
were sorted as Lin-CD115+CD135+CD117int cells as above. Ly6G, NK1.1, 
Ter119, MHCII, B220, CD3, CD11c, and CD19 lineage markers were used 
prior negative selection. The isolated CDPs were then transfected with miR-
124 mimic or control mimic (cel-miR-39) before being cultured with BM filler 
cells extracted from CD45.1 mice in Flt3L-conditioned media. The general 
outline of the protocol and diagrammed in Figure 15A. Ginhoux et al. were 
able to observe pre-DCs derived from CD45.2 CDPs 2 days after culture and 
matureDCs 4 days after culture.21 Cells were thus harvested 2 and 4 days post-
culture and analyzed by FACS for pre-DC and matureDC subpopulations. 
Figure 15B shows the FACS analyses of CD45.2+ cells transfected with miR-
124 or control mimic and cultured for 4 days. Gating with matureDC markers 
showed no significant change in pDC development; however, there was drastic 
change in cDC development. There were conspicuous changes in cDC2 
development. Both transfection groups showed lack of cDC1 development and 
also identified a previously unrecognized DC subset carrying matureDC 
markers. Overexpression of miR-124 seems to cause a decrease in 
development of this population of CD172αhighCD24high cells (Figure 15B).
The transfection of miR-124 mimic into CDPs did not cause any change in 
pre-DC populations at day 2 of culture (data not shown). Also, transfection of 
miR-124 inhibitor did not induce any changes in CDP cultures (data not 
shown). 
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Figure 15. Effects of miR-124 mimic transfection on DC subset 
development. (A) Diagrammed protocol of mimic-transfected CDP culture 
experiment. (B) FACS analysis of matureDC populations derived from the 
transfected CDPs 4 days post-seeding. Population percentages are labeled. 
Representative flow cytograms from 2 independent experiments are shown.
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IV. Discussion
MicroRNA-124 is known as the most abundant microRNA expressed 
in neuronal cells.2, 25 Although many miRNA are starting to being linked to 
immunological processes, miR-124 remains unmentioned. Even in 
comprehensive cluster analyses of miRNA in hematopoietic and immunologic 
cell lines failed to recognize involvement of miR-124. Thus, the outstanding 
and differential expression of miR-124 in Flt3L-cultured DC populations was 
intriguing as it was paralleled with DC development. Since lymphoid-organ 
DC maintenance in vivo is critically dependent on Flt3L, the physiological 
relevance of the steady-state populations, the appropriateness of the model to 
study pDC and cDC origins, and the novelty of miR-124 in this context led us 
to focus on this initiative. This study thus aimed to critically define the 
dynamic profile of miR-124 in the subpopulations and delineate its interplay 
with relevant transcription factors that manipulate the development of 
particular subsets and also the functional capacities of these subsets.
Analyzing the prediction algorithm software, Tcf4 was shown to be a 
probable target of miR-124 while Zbtb46 was shown to be a less likely target. 
Symmetrical to the prediction software, the luciferase activity assay showed 
that miR-124 mimic binds to the inserted 3’UTR section of Tcf4. Since Tcf4 
has been established to be a critical gene in the development and homeostasis 
of pDCs, this data suggested that miR-124 may play a major role in this 
process. This led us to hypothesize that miR-124 would be least expressed in 
pDCs, as a high expression would more effectively target Tcf4 mRNA for 
degradation and inhibit pDC growth. The miR-124 expression profiling of in 
vitro-generated DC subsets correlated with our hypothesis in that it was least 
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expressed in the pDC subset. Although, the Flt3L culture system has been 
established as a proficient scheme for DC investigation, it does not completely 
mimic in vivo conditions; thus it was necessary to study steady-state in situ
conditions. Expression profiling in steady-state BM and spleen also showed 
least amount of miR-124 expression in the pDC subset. However, the most 
peculiar data was in the outstanding expression of miR-124 in cultured pre-
DCs, and in cDC1cells for steady-state conditions. There was an unexpected 
difference in the dynamic miR-124 expression profiles between in vitro-
generated and steady-state in situ DC subpopulations. These patterns were not 
spontaneous and were repeated consistently in parallel trials. The drastically 
higher expression of miR-124 in cultured pre-DCs compared to that in 
matureDCs again suggested an internal switch for miR-124 activity during DC 
development. Meanwhile, the analysis of the pre-DC subpopulations indicates 
that the high expression of miR-124 in cultured pre-DCs was not due to the 
prevalence of a particular pre-DC subset with high miR-124 expression in 
Flt3L-cultured conditions. This first and foremost hinted that miR-124, like 
most other miRNAs, does not act on DC development one-dimensionally 
through a single transcription factor, but instead acts through a complex 
orchestra of relevant factors. In a recent publication, miR-124 was reported to 
be linked to the NF-kB pathway.7 Second, these observations led us to 
reinvestigate our subset differentiation methods in the culture system and also 
consider Flt3L as a factor that may influence miR-124 expression. In light of 
these theories, it is though more evident that miR-124 activity is highly 
dynamic during DC development and indicates to an existence of purpose for 
such fluctuation.
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Consequently, miR-124 overexpression and inhibition protocols were 
planned to observe the phenotypic changes of DC developmental patterns 
influenced by the miRNA. miR-124 knock-out mice do not currently exist as 
miR-124 have three precursor transcripts originating from three pri-miR-124 
genes on independent chromosomes. As demonstrated, all three precursor 
genes also contribute in the expression of mature miR-124 in DC subsets. 
Currently, the triple pri-miR-124 knock-out mice does not seem to be expected 
to be generated in the near future. 
For the present study, LNA miR-124 mimic (or inhibitor) was used 
with a nucleofection process in order to observe the effects of miR-124 
overexpression (or inhibition). Nucleofection has been increasingly linked to 
efficient short nucleotide sequence transfection for infamously hard-to-
transfect cells including non-adherent lymphocyte-like cells. Transfection of 
CDPs with this method and subsequent co-culture with filler cells in Flt3L 
caused a complete lack of development of the cDC1 lineage. However, this 
observation was observed in both miR-124 mimic and control mimic (cel-
miR-39-3p) transfected cells. Cel-miR-39-3p is known to have no targets and 
is an established control mimic for such studies. This observation suggests that 
the shock process or reagents involved in nucleofection might have caused 
such an outcome, and this is currently being further investigated. The 
nucleofection process also identified a previously unrecognized DC subset 
with matureDC and precursor markers. The identity of this population and its 
relation to cDC subsets are being investigated. However, it is important to note 
that, miR-124 expression caused a decrease in this population. These 
observations were unexpected but the data gives us increasing evidence of the 
significant influence that miR-124 on DC development. 
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V. Conclusion
miR-124 was shown to directly target the transcription factor Tcf4, 
which is a pivotal regulator of DC development. miR-124 was shown to be 
highly expressed in pre-DCs from BM cultured with Flt3L. However, in in situ
BM and spleen at steady-state, miR-124 was shown to be most highly 
expressed in cDC1 cells. The dynamic expression profile of miR-124 was 
different between but consistent within the in vitro-generated DC subsets and 
in situ BM DCs. Transfection of miR-124 mimic into BM CDP followed by 
culture with Flt3L caused significant changes in resulting matureDC
populations, where large changes in cDC1 and cDC2 lineages were observed. 
From our present study, the expression of miR-124 identified previously 
unrecognized DC subsets carrying DC markers of mature and precursor states, 
which is being further investigated. These observations suggest that miR-124 
plays an important and mechanistic role in the development of DC subsets.
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수지상 세포의 분화에 따라 조절되는 microRNA 의 분석
<지도교수 박채규>
연세대학교 대학원 의과학과
한선
Abstract
수지상세포(dendritic cells, DCs)는 항원 특이적인 T세포 반
응을 유도하는 전문화된 항원제시세포로서 cDC1과 cDC2로 세분화
되는 classical 수지상세포(cDC)와 plasmacytoid 수지상세포(pDC)
등 다양한 아형이 존재한다. 수지상세포 아형에 특이적으로 발현되
는 전사인자에 대한 연구는 다수 보고되었으나, 수지상세포 분화 과
정에 관여하는 전사인자들의 발현을 조절하는 정확한 기전에 대한
연구는 아직 미비하다. microRNA(miRNA)는 체내 여러 유전자의 발
현을 전사후 과정에서 조절하는 중추적인 조절인자로 알려져 있으나
면역계에서의 역할과 작용에 대한 연구는 부족하다. 본 연구자는 수
지상세포의 발달과 기능 형성에 관여하는 miRNA를 찾고자 수지상
세포의 발달과 연관성이 있는 전사인자들의 3’UTR을 표적으로 하는
miRNA를 스크리닝하였다. 이를 통해 pDC의 분화와 기능에 관여하
는 전사인자 Tcf4의 3’UTR이 miR-124의 표적이 될 수 있음을 확
인하였다. In vitro에서 마우스 골수세포를 Flt3L와 함께 배양한 후
수지상세포의 아형들을 분리하여 qPCR로 확인한 결과 cDC의 전구
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세포에서 miR-124가 현저히 높게 발현하는 것을 관찰하였다. 배양
하지 않은 마우스 골수에서는 수지상세포의 전구세포, pDC 및
CD172a+ cDC2 보다 CD24+ cDC1에서 miR-124의 발현이 높게 나
타났다. 수지상세포의 분화 과정에서 miR-124가 어떠한 작용을 하
는지 확인하기 위하여 miR-124의 mimic 또는 억제제를 마우스 골
수에서 분리한 수지상세포 공통전구체(common DC progenitor, CDP)
에 transfection한 후 Flt3L와 함께 배양하였다. 그 결과 기존에 보
고된 바 없는 수지상세포 아형의 숫자가 크게 감소하는 것을 발견하
였다. 본 연구를 통하여 miR-124가 수지상세포의 분화 과정 기전에
관여하는 것을 확인하였고, 나아가서 수지상세포의 복잡한 분화 과
정을 더 깊이 이해할 수 있는 근거를 제시하였다. 
핵심되는 말: 수지상세포, microRNA, 아형, 분화, Flt3L, 전사후 조절
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